16th Biennial European Conference: http://smdm.org/meeting/16th-biennial-european-meeting

16th Biennial European Conference
June 12 - 14, 2016

Menu

  • Search
  • Browse
  • Browse by Program
  • Ebooks
  • Author Index

Vimalanand S. Prabhu, B.E, M.Mgmt, Ph.D.

Principal Scientist
Merck and Co., Inc.
Health Economic Statistics
2000 Galloping Hill Road
PO Box 539
Kenilworth, NJ
USA 09033-1310
Email: vimalanand.prabhu@merck.com

Papers:
2E-2 BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS 2E-5 COST-EFFECTIVENESS OF BEZLOTOXUMAB+STANDARD OF CARE (SOC) VERSUS PLACEBO+SOC FOR THE PREVENTION OF RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN THE UNITED STATES 2E-6 BUDGET IMPACT OF FIDAXOMICIN COMPARED WITH VANCOMYCIN FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN THE UNITED STATES

Menu

  • Search
  • Browse
  • Browse by Program
  • Ebooks
  • Author Index
Meeting Information

When:

June 12 - 14, 2016

Where:

London, United Kingdom